Comprehensive cannabinoid profiling from whole blood by LC-MS/MS. Cannabis therapy monitoring for research.
This research panel provides quantitative profiling of 11 cannabinoids and metabolites from whole blood, supporting cannabis therapy monitoring and pharmacokinetic research.
Clinical indications include:
11 cannabinoids: CBD, THC, CBG, CBN, CBC, and their primary metabolites.
All 11 cannabinoids are quantified simultaneously by LC-MS/MS from whole blood, with chromatographic separation of isobaric species (CBD/THC) and stable isotope internal standardisation.
Cannabinoid Panel is an important biomarker for cannabis therapy monitoring in clinical research. Masdiag measures cannabinoid panel using validated analytical methods to provide clinically actionable results.
Cannabinoid Panel testing is valuable for Cannabis therapy monitoring in clinical research, Pharmacokinetic studies of cannabinoid preparations. Understanding cannabinoid panel levels helps inform personalized health optimization and clinical decision-making.
Cannabinoid Panel is measured from blood. Professional collection ensures proper sample handling and accurate results.
This test is recommended for individuals interested in cannabis therapy monitoring in clinical research. Masdiag cannabinoid panel testing helps guide personalized supplementation and health optimization strategies based on objective biomarker data.
Cannabinoid Panel results provide insight into your metabolic status and cannabis therapy monitoring in clinical research. Combined with clinical context, Masdiag results inform evidence-based interventions for personalized health optimization.
Whether you need testing services, method transfer, or white-label kit development — we'd love to hear from you.